Tirzepatide improves the metabolic features of PCOS (insulin resistance, anovulation) rather than causing it
Whether youre evaluating cost-effectiveness, optimizing adherence or designing a lifestyle program to accompany pharmacotherapy, the right data makes the difference
Medical Eligibility and Risk Factors That Affect Tolerability Patients with prior pancreatitis, thyroid disease history, or severe gastroparesis may have reduced tolerability across all GLP-1 agents and require closer medical supervision or alternative approaches
Mild fatigue or lightheadedness during the first weeks of MOTS-c (AMPK adaptation)
It seems like every few months, a new compound emerges that pushes the boundaries of what we thought was possible in metabolic science
Retatrutide is still an investigational peptide that has not yet completed the full FDA review process to establish its long-term safety and effectiveness profile